Der var tilsvarende ingen forskelle mellem grupperne i det pivotale studie med Bonviva- injektion 3 mg hver 3. måned (BM 16550).
Similarly, no differences were noted between the groups in the pivotal study with Bonviva 3 mg injection every 3 months (BM 16550).